Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal esketamine crossover cognition study in healthy adults
NL-OMON40652Active, not recruiting
- Sponsor
- Janssen Pharmaceutical
- Start
- Jun 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of esketamine (2 arms), sponsored by Janssen Pharmaceutical. Primary endpoint: Cognitive functioning. Started Jun 2014; status: active, not recruiting.
02
Drugs
esketamine
Beyond the preview
Go deeper on NL-OMON40652.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON40652.